Researchers Identify SARS-CoV-2 Proteins That Play Major Role in Immune Suppression

The discovery of which proteins specifically contribute to immune suppression could help align treatment methods.

Key Highlights

  • The study focused on understanding how SARS-CoV-2 proteins interfere with the body's initial immune defenses.
  • Mutations in NSP1 and NSP15 triggered stronger antiviral responses compared to the original virus.
  • Nine out of twelve viral proteins tested showed some ability to suppress immune activity.
  • Single-cell RNA sequencing revealed changes in immune cell activation patterns in infected mice lungs.
  • Findings suggest SARS-CoV-2 uses multiple, overlapping mechanisms to evade immune detection.

Researchers at the University of Texas Medical Branch (UTMB) have identified “two SARS-CoV-2 proteins that play a major role in helping the virus suppress the body’s early immune defenses.”

In a new study, scientists “examined how SARS-CoV-2 uses a collection of viral proteins to interfere with the innate immune response—the body’s first line of defense against infection.” The researchers specifically wanted to understand the relative importance of different proteins to dampening immune activity. They “engineered 12 recombinant versions of SARS-CoV-2, each carrying mutations in a different viral protein.”

Using those versions, the researchers “compared how the immune system responded to each modified virus. The study revealed that among 12 tested proteins, mutations in two—NSP1 and NSP15—triggered significantly stronger antiviral immune responses than the original virus, with nine of the 12 proteins showing some immune-suppressing activity.”

Using single-cell RNA sequencing, the researchers were also able to identify “broad changes in immune cell activation patterns in the lungs of infected mice, including effects on myeloid and lymphoid immune cell populations.” The findings demonstrate that ‘SARS-CoV-2 relies on multiple, overlapping mechanisms to suppress immune activity and avoid detection.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates